CCP 11B-9, Thymus Tissue Implantation will become effective June 1, 2023. This policy addresses thymus tissue implantation (also known as culture thymus tissue [CTT] implantation) using allogeneic processed thymus tissue (allogeneic processed thymus tissue-agdc [RETHYMIC®], Enzyvant Therapeutics, Inc. Cambridge, MA) a regenerative therapy used for immune reconstitution in children with congenital athymia.
NC Medicaid shall require prior approval for Thymus Tissue Implantation. The provider shall obtain prior approval before rendering Thymus Tissue Implantation. The provider shall use CPT code 60699 in NCTracks when entering PA for Thymus Tissue Implantation.
Providers are encouraged to review Clinical Coverage Policy 11B-9, Thymus Tissue Implantation on the Program Specific Clinical Coverage Policies webpage for a detailed overview.
NCTracks Call Center: 800-688-6696